Zetamax may be available in the countries listed below.
Ingredient matches for Zetamax
Azithromycin
Azithromycin is reported as an ingredient of Zetamax in the following countries:
- Russian Federation
International Drug Name Search
Friday 26 November 2010
Wednesday 24 November 2010
Xyzal
Xyzal is a brand name of levocetirizine, approved by the FDA in the following formulation(s):
XYZAL (levocetirizine dihydrochloride - solution; oral)
Manufacturer: UCB INC
Approval date: January 28, 2008
Strength(s): 2.5MG/5ML [RLD][AA]
XYZAL (levocetirizine dihydrochloride - tablet; oral)
Manufacturer: UCB INC
Approval date: May 25, 2007
Strength(s): 5MG [RLD][AB]
Has a generic version of Xyzal been approved?
A generic version of Xyzal has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Xyzal and have been approved by the FDA:
levocetirizine dihydrochloride solution; oral
Manufacturer: SYNTHON PHARMS
Approval date: November 7, 2011
Strength(s): 2.5MG/5ML [AA]
levocetirizine dihydrochloride tablet; oral
Manufacturer: DR REDDYS LABS LTD
Approval date: February 24, 2011
Strength(s): 5MG [AB]
Manufacturer: GLENMARK GENERICS
Approval date: February 24, 2011
Strength(s): 5MG [AB]
Manufacturer: SYNTHON PHARMS
Approval date: November 26, 2010
Strength(s): 5MG [AB]
Manufacturer: TEVA PHARMS
Approval date: August 22, 2011
Strength(s): 5MG [AB]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Xyzal. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Methods for treating allergic disorders using optically pure (-) cetirizine
Patent 5,698,558
Issued: December 16, 1997
Inventor(s): Gray; Nancy M.
Assignee(s): Sepracor, Inc.
Methods are disclosed utilizing optically pure (-) cetirizine for the treatment of seasonal and perennial allergic rhinitis in humans while avoiding the concomitant liability of adverse effects associated with the racemic mixture of cetirizine. The optically pure (-) isomer is also useful for the treatment of allergic asthma.Patent expiration dates:
- September 24, 2012✓
- September 24, 2012✓
- March 24, 2013✓
- September 24, 2012
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- November 25, 2010 - PEDIATRIC EXCLUSIVITY
- August 21, 2012 - NEW PATIENT POPULATION
- February 21, 2013 - PEDIATRIC EXCLUSIVITY
See also...
- Xyzal Consumer Information (Drugs.com)
- Xyzal Consumer Information (Wolters Kluwer)
- Xyzal Solution Consumer Information (Wolters Kluwer)
- Xyzal Consumer Information (Cerner Multum)
- Xyzal Advanced Consumer Information (Micromedex)
- Xyzal AHFS DI Monographs (ASHP)
- Levocetirizine Consumer Information (Wolters Kluwer)
- Levocetirizine Solution Consumer Information (Wolters Kluwer)
- Levocetirizine Consumer Information (Cerner Multum)
- Levocetirizine Advanced Consumer Information (Micromedex)
- Levocetirizine Dihydrochloride AHFS DI Monographs (ASHP)
Zinacef
Zinacef is a brand name of cefuroxime, approved by the FDA in the following formulation(s):
ZINACEF (cefuroxime sodium - injectable; im-iv)
Manufacturer: GLAXOSMITHKLINE
Approval date: October 19, 1983
Strength(s): EQ 750MG BASE/VIAL [RLD][AB]
ZINACEF (cefuroxime sodium - injectable; injection)
Manufacturer: GLAXOSMITHKLINE
Approval date: October 19, 1983
Strength(s): EQ 1.5GM BASE/VIAL [RLD][AP]
Manufacturer: GLAXOSMITHKLINE
Approval date: October 23, 1986
Strength(s): EQ 7.5GM BASE/VIAL [RLD][AP]
Has a generic version of Zinacef been approved?
Yes. The following products are equivalent to Zinacef:
cefuroxime sodium injectable; im-iv
Manufacturer: APP PHARMS
Approval date: May 30, 2001
Strength(s): EQ 750MG BASE/VIAL [AB]
Manufacturer: HIKMA FARMACEUTICA
Approval date: January 9, 2004
Strength(s): EQ 750MG BASE/VIAL [AB]
Manufacturer: STERI PHARMA
Approval date: May 30, 1997
Strength(s): EQ 750MG BASE/VIAL [AB]
Manufacturer: TEVA
Approval date: April 16, 1998
Strength(s): EQ 750MG BASE/VIAL [AB]
cefuroxime sodium injectable; injection
Manufacturer: APP PHARMS
Approval date: September 28, 1998
Strength(s): EQ 7.5GM BASE/VIAL [AP]
Manufacturer: APP PHARMS
Approval date: May 30, 2001
Strength(s): EQ 1.5GM BASE/VIAL [AP]
Manufacturer: HIKMA FARMACEUTICA
Approval date: January 9, 2004
Strength(s): EQ 1.5GM BASE/VIAL [AP], EQ 7.5GM BASE/VIAL [AP]
Manufacturer: HOSPIRA INC
Approval date: October 15, 2008
Strength(s): EQ 1.5GM BASE/VIAL [AP], EQ 1.5GM BASE/VIAL [AP], EQ 7.5GM BASE/VIAL [AP]
Manufacturer: STERI PHARMA
Approval date: May 30, 1997
Strength(s): EQ 1.5GM BASE/VIAL [AP], EQ 7.5GM BASE/VIAL [AP]
Manufacturer: TEVA
Approval date: April 16, 1998
Strength(s): EQ 1.5GM BASE/VIAL [AP], EQ 7.5GM BASE/VIAL [AP]
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Zinacef. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
There are no current U.S. patents associated with Zinacef.
See also...
- Zinacef Consumer Information (Wolters Kluwer)
- Zinacef Advanced Consumer Information (Micromedex)
- Cefuroxime Consumer Information (Wolters Kluwer)
- Cefuroxime Suspension Consumer Information (Wolters Kluwer)
- Cefuroxime Tablets Consumer Information (Wolters Kluwer)
- Cefuroxime Consumer Information (Cerner Multum)
- Cefuroxime Advanced Consumer Information (Micromedex)
- Cefuroxime Injection, Intravenous Advanced Consumer Information (Micromedex)
- Cefuroxime Axetil AHFS DI Monographs (ASHP)
- Cefuroxime Sodium AHFS DI Monographs (ASHP)
Saturday 13 November 2010
Allylestrénol
Allylestrénol may be available in the countries listed below.
Ingredient matches for Allylestrénol
Allylestrenol
Allylestrénol (DCF) is also known as Allylestrenol (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Click for further information on drug naming conventions and International Nonproprietary Names.
Tamoxifeno Funk
Tamoxifeno Funk may be available in the countries listed below.
Ingredient matches for Tamoxifeno Funk
Tamoxifen
Tamoxifen citrate (a derivative of Tamoxifen) is reported as an ingredient of Tamoxifeno Funk in the following countries:
- Spain
International Drug Name Search
Friday 12 November 2010
Gored
Gored may be available in the countries listed below.
Ingredient matches for Gored
Gliclazide
Gliclazide is reported as an ingredient of Gored in the following countries:
- Bangladesh
International Drug Name Search
Tuesday 9 November 2010
Abaktal
Abaktal may be available in the countries listed below.
Ingredient matches for Abaktal
Pefloxacin
Pefloxacin is reported as an ingredient of Abaktal in the following countries:
- Bosnia & Herzegowina
- Bulgaria
- Croatia (Hrvatska)
- Czech Republic
- Georgia
- Latvia
- Lithuania
- Poland
- Romania
- Russian Federation
- Slovakia
International Drug Name Search
Sunday 7 November 2010
Zofixi-CL
Zofixi-CL may be available in the countries listed below.
Ingredient matches for Zofixi-CL
Cefixime
Cefixime is reported as an ingredient of Zofixi-CL in the following countries:
- India
Clavulanate
Clavulanic Acid is reported as an ingredient of Zofixi-CL in the following countries:
- India
International Drug Name Search
Wednesday 3 November 2010
Distalene
Distalene may be available in the countries listed below.
Ingredient matches for Distalene
Anastrozole
Anastrozole is reported as an ingredient of Distalene in the following countries:
- Argentina
International Drug Name Search
Tuesday 2 November 2010
Bioflutikazon
Bioflutikazon may be available in the countries listed below.
Ingredient matches for Bioflutikazon
Fluticasone
Fluticasone is reported as an ingredient of Bioflutikazon in the following countries:
- Poland
International Drug Name Search
Betaferon
Betaferon may be available in the countries listed below.
UK matches:
- Betaferon
Ingredient matches for Betaferon
Interferon beta
Interferon beta Interferon beta-1b (a derivative of Interferon beta) is reported as an ingredient of Betaferon in the following countries:
- Argentina
- Australia
- Austria
- Bahrain
- Belgium
- Bosnia & Herzegowina
- Brazil
- Chile
- Croatia (Hrvatska)
- Czech Republic
- Denmark
- Dominican Republic
- Finland
- France
- Georgia
- Germany
- Greece
- Hong Kong
- Hungary
- Iceland
- India
- Indonesia
- Ireland
- Israel
- Italy
- Japan
- Luxembourg
- Malaysia
- Netherlands
- New Zealand
- Norway
- Oman
- Peru
- Poland
- Portugal
- Romania
- Russian Federation
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sweden
- Switzerland
- Taiwan
- Thailand
- Turkey
- United Kingdom
International Drug Name Search
Subscribe to:
Posts (Atom)